Dr Boreham's Crucible: Argenica Therapeutics
Argenica Therapeutics is aiming for a substantial slice of the stroke market, expected to be worth some US$180bn a year by 2030
Source: fnarena.com
Stay updated with breaking news from Terry Budge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Argenica Therapeutics is aiming for a substantial slice of the stroke market, expected to be worth some US$180bn a year by 2030